scholarly journals An Ayurvedic management of PCOD: A Review

2018 ◽  
Vol 6 (5th) ◽  
Author(s):  
Supriya Chikhalekar ◽  
Ramesh Bansode
Keyword(s):  
Reproductive Age ◽  
Endocrine Disorders ◽  
Dietary Management ◽  
Women Of Reproductive Age ◽  
Menstrual Irregularities ◽  
Prevention And Cure ◽  
Ovarian Syndrome

PCOD can be managed with Ayurvedic diet. Ovarian Syndrome is one of the most common female endocrine disorders affecting approximately 5% to 10% of women of reproductive age and is thought to be one of theleading causes of female sub-fertility. The symptoms of PCOS may begin in adolescence with menstrual irregularities, infertility, high levels of masculinising hormones, metabolic syndromes.In Ayurveda, this condition is not explained as a single disease, but can be  under the headings of Yonivyapad and Artavadushti. In this study, elementary books of Ayurveda and modern were searched and analyzed for proper utilization in prevention and cure of PCOS. PCOS is an emerging problem among women leading to endocrine dysfunction.Treatment modalities aim at clearing obstruction in pelvis, treating Agnimandhya at Jatharagni,Dhatwagni level and alleviating Srotoavarodha and ultimately regularizing the Apana Vata. PCOD can be managed with Ayurvedic dietary management.

scholarly journals Short Review on Polycystic Ovarian Syndrome

2017 ◽  
Vol 19 (1) ◽  
pp. 49-53
Author(s):  
Rabia Farooq
Keyword(s):  
Polycystic Ovarian Syndrome ◽  
Endocrine System ◽  
Short Review ◽  
Reproductive Age ◽  
Women Of Reproductive Age ◽  
The World ◽  
Long Time ◽  
System Disorder ◽  
Ovarian Syndrome

Polycystic ovarian syndrome (PCOS) is a metabolic disease and a common endocrine system disorder among women of reproductive age. Infrequent or prolonged menstrual periods, excess hair growth, acne, and obesity can occur in women with PCOS. Early diagnosis and treatment along with weight loss may reduce the risk of long-term complications. Now a days PCOS is also the cause of infertility. India is PCOS capital of the world. PCOS management is necessary to reduce its long time complications.J MEDICINE Jan 2018; 19 (1) : 49-53

scholarly journals Study of cutaneous manifestations of polycystic ovarian syndrome

2020 ◽  
Vol 9 (4) ◽  
pp. 1627
Author(s):  
Sukhleen Kaur ◽  
Sunil K. Gupta ◽  
Sunil K. Juneja ◽  
Sukhjot Kaur ◽  
Monika Rani
Keyword(s):  
Insulin Resistance ◽  
Acanthosis Nigricans ◽  
Polycystic Ovarian Syndrome ◽  
Free Testosterone ◽  
Reproductive Age ◽  
Common Finding ◽  
Serum Prolactin ◽  
Endocrine Disorders ◽  
Cutaneous Manifestations ◽  
Ovarian Syndrome

Background: Polycystic ovarian syndrome (PCOS) is one of the most frequently encountered endocrine disorders that occurs in as many as 4 to 10% of women of reproductive age group. It presents with a series of skin changes including acne, hirsutism, seborrhea, androgenetic alopecia (AGA) and acanthosis nigricans. Aim of the study was to determine the prevalence and frequency of different cutaneous manifestations in PCOS patients and to correlate them with the degree of hormonal abnormalities.Methods: A total 100 patients with features of PCOS who presented to department of dermatology, gynecology (January 2018-December 2019) with cutaneous manifestations were recorded and diagnosis of PCOS was made using Rotterdam’s criteria. Pregnant women and diagnosed cases of any other endocrine disorder were excluded. Hirsutism was assessed using Ferriman-Gallwey score and AGA according to Ludwig’s classification. Serum hormonal profile including FSH, LH, prolactin, testosterone (free), DHEAS, TSH, FBS, fasting insulin were done. Insulin resistance was determined by calculating HOMA-IR score.Results: Among cutaneous manifestations of PCOS, hirsutism (85%) was the most common finding followed by acne (73%), seborrhea (50%), AGA (36%), acanthosis nigricans (29%) and acrochordons (9%). The most common hormonal abnormality was insulin resistance in 53% patients, followed by raised free testosterone in 19% and serum prolactin in 18% patients. A statistically significant association was present between AGA and insulin resistance, hirsutism and raised prolactin levels, seborrhea and raised body mass index (p < 0.05).Conclusions: Dermatological manifestations of PCOS play a significant role in making the diagnosis and constitute a substantial portion of the symptoms experienced by women with this syndrome.

scholarly journals Role of oral inositol supplementation in women with polycystic ovarian syndrome

2021 ◽  
Vol 10 (12) ◽  
pp. 4493
Author(s):  
Najma Malik ◽  
Navneet Dubey
Keyword(s):  
Insulin Resistance ◽  
Prospective Observational Study ◽  
Oocyte Quality ◽  
Reproductive Age ◽  
Women Of Reproductive Age ◽  
Medical College ◽  
Good Medicine ◽  
Ovarian Syndrome ◽  
Rotterdam Criteria

Background: PCOS is one of the most common endocrine disorder in women of reproductive age, it affects about 5-10% of women of reproductive age. It is characterized by chronic anovulation, hyperandrogenism, and insulin resistance. 30-40% of PCOS women have impaired glucose tolerance.Methods: This was prospective observational study carried out on 100 patients of PCOS visiting outpatient Department of Obstetrics and Gynecology, BRD Medical College, Gorakhpur from 1st July 2018 to 30th June 2019. Patients were diagnosed as PCOS on basis of Rotterdam criteria. In these 100 patients, oral inositol 2 gm twice daily was given for 3 months to 6 months depending upon the response of the patient and patients were examined every 4 week for menstrual regularity, acne improvement, hirsutism, spontaneous ovulation and pregnancy.Results: With inositol supplementation, menstrual abnormality corrected in 80% cases, 45% cases having acne improved. Ovulation occurred in 75.5% cases and 66.6% cases conceived with inositol supplementation.Conclusions: Insulin resistance is the basic pathophysiology for PCOS hence inositol supplementation is supposed to be very good medicine for management of PCOS to improve insulin sensitivity. Inositol leads to improvement in regularity of menstrual cycle, insulin resistance, hyperandrogenic features like hirsutism, acne, restores ovulation and improves oocyte quality.

scholarly journals Image Denoising for the Detection of Follicle in Polycystic Ovarian Syndrome Images

2018 ◽  
Vol 7 (2) ◽  
pp. 118-122
Author(s):  
A. Saravanan ◽  
S. Sathiamoorthy
Keyword(s):  
Computer Vision ◽  
Image Denoising ◽  
Polycystic Ovarian Syndrome ◽  
Image Representation ◽  
Reproductive Age ◽  
Vision Systems ◽  
Women Of Reproductive Age ◽  
Fuzzy C Means Clustering ◽  
Computer Vision Systems ◽  
Ovarian Syndrome

Polycystic Ovarian Syndrome is an endocrine ailment affecting women of reproductive age. This syndrome is largely found in women whose age is in between 25 and 35. Without knowing the accurate region of a follicle in ovary, the hazard rigorousness of the patient cannot be exposed. Since, super-pixels can be functional on segmentation and image representation, it has turned out to be essential for refining the competence in computer vision systems. Thus, in this paper, a novel image denoising methodology for the detection of a follicle in the PCOS has been suggested by exploring the super-pixel clustering and Fuzzy C means clustering.

scholarly journals Study on the Prevalence and Characteristics of Metabolic Syndrome in Women of Reproductive Age Group with Polycystic Ovarian Syndrome

2017 ◽  
Vol 9 (4) ◽  
pp. 341-347
Author(s):  
Rekha R Madusudhanan ◽  
Bindu Nambisan ◽  
Mayadevi Brahmanandan ◽  
Sreekumari Radha
Keyword(s):  
Metabolic Syndrome ◽  
Polycystic Ovarian Syndrome ◽  
Significant Risk ◽  
Significant Risk Factor ◽  
Reproductive Age ◽  
Age Group ◽  
Women Of Reproductive Age ◽  
Ovarian Syndrome ◽  
Reproductive Age Group

ABSTRACT Introduction Polycystic ovarian syndrome (PCOS) is an endocrine disorder affecting all age groups and presenting with myriad problems like menstrual irregularities, hirsutism, anovulatory infertility, and long-term complications like diabetes, cardiovascular problems, etc. Aim Study was aimed at finding the prevalence, characteristics, and various risk factors of metabolic syndrome (MS) in reproductive age group in our hospital. Materials and methods Using statistical table, a sample size of 131 was calculated and patients were recruited as per inclusion criteria. Polycystic ovarian syndrome was diagnosed by the American Society for Reproductive Medicine (ASRM)/European Society of Human Reproduction and Embryology (ESHRE) criteria. After informed consent, a detailed history was obtained and physical examination was carried out to assess, body weight, height, body mass index (BMI), waist—hip ratio (WHR), and blood pressure (BP). Fasting blood glucose, triglycerides, and high-density lipoprotein (HDL) were measured for each woman Results Prevalence of MS in our study was 45.8%; 26.7% of patients had a combination of increased waist circumference, raised triglycerides, and low HDL; 55.2% of patients had a fasting blood sugar (FBS) levels more than 100 mg%. Age of the patient was a statistically significant risk factor of MS with 100% of patients in the age group of 35 to 39 presenting with MC. Body mass index was also a statistically significant risk factor with 82.6% with BMI > 30 having MC. Other important risk factors include a WHR more than 0.95, presence of diabetes in mother or sister, and presence of acanthosis; 71% of patients with WHR more than 0.95 had MC. Age of menarche, duration of menstrual cycles, and hirsutism showed no significant relationship. Conclusion An outstanding fact that emerged in this study was that 94% of women with PCOS had HDL values <50 mg/dL. And 58% had triglycerides more than 150 mg/dL. Hence, lifestyle modification and early intervention will hopefully spare long-term complication of PCOS. How to cite this article Madusudhanan RR, Nambisan B, Brahmanandan M, Radha S. Study on the Prevalence and Characteristics of Metabolic Syndrome in Women of Reproductive Age Group with Polycystic Ovarian Syndrome. J South Asian Feder Obst Gynae 2017;9(4):341-347.

scholarly journals Headaches and papilloedema in a pregnant woman with polycystic ovarian syndrome

2011 ◽  
Vol 4 (1) ◽  
pp. 28-29
Author(s):  
Adam Morton
Keyword(s):  
Pregnant Woman ◽  
Intracranial Hypertension ◽  
Idiopathic Intracranial Hypertension ◽  
Polycystic Ovarian Syndrome ◽  
Rare Condition ◽  
Reproductive Age ◽  
Obese Women ◽  
Women Of Reproductive Age ◽  
New Diagnosis ◽  
Ovarian Syndrome

Idiopathic intracranial hypertension (IIH) is a rare condition, its highest incidence being in obese women of reproductive age. A woman with polycystic ovarian syndrome and IIH is presented, a new diagnosis during pregnancy resulting in a change in her management.

Sign in / Sign up

Export Citation Format

Share Document